Cargando…
Inducing Mitotic Catastrophe as a Therapeutic Approach to Improve Outcomes in Ewing Sarcoma
SIMPLE SUMMARY: Ewing sarcoma (EWS) is a rare pediatric sarcoma affecting children and adolescents, with median diagnosis around the age of 15. Despite an intensive therapeutic regimen, including chemotherapy, surgery/radiation patients with recurrent (10–15%) and metastatic disease (<30%) have p...
Autores principales: | Turaga, Soumya M., Vishwakarma, Vikalp, Hembruff, Stacey L., Gibbs, Benjamin K., Sabu, Priya, Puri, Rajni V., Pathak, Harsh B., Samuel, Glenson, Godwin, Andrew K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605681/ https://www.ncbi.nlm.nih.gov/pubmed/37894278 http://dx.doi.org/10.3390/cancers15204911 |
Ejemplares similares
-
Identification of small extracellular vesicle protein biomarkers for pediatric Ewing Sarcoma
por: Turaga, Soumya M., et al.
Publicado: (2023) -
MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation
por: Crow, Jennifer, et al.
Publicado: (2022) -
CDC7 kinase (DDK) inhibition disrupts DNA replication leading to mitotic catastrophe in Ewing sarcoma
por: Martin, Jeffrey C., et al.
Publicado: (2022) -
WEE1 Inhibition Augments CDC7 (DDK) Inhibitor–induced Cell Death in Ewing Sarcoma by Forcing Premature Mitotic Entry and Mitotic Catastrophe
por: Martin, Jeffrey C., et al.
Publicado: (2022) -
Ewing sarcoma family of tumors-derived small extracellular vesicle proteomics identify potential clinical biomarkers
por: Samuel, Glenson, et al.
Publicado: (2020)